Cargando…

Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling

Platelet-derived growth factor-BB (PDGF-BB) and its downstream effector, extracellular signal-regulated kinase 1/2 (ERK1/2) MAP kinase, initiate a multitude of biological effects, including vascular smooth muscle cell (VSMC) proliferation and migration, which are critical events in the initiation an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lan, Zhao, Rui, Lan, Xi, Chen, Ruoyun, Wang, Si, Du, Guanhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271974/
https://www.ncbi.nlm.nih.gov/pubmed/25432005
http://dx.doi.org/10.3390/molecules191219501
_version_ 1783377052752150528
author Sun, Lan
Zhao, Rui
Lan, Xi
Chen, Ruoyun
Wang, Si
Du, Guanhua
author_facet Sun, Lan
Zhao, Rui
Lan, Xi
Chen, Ruoyun
Wang, Si
Du, Guanhua
author_sort Sun, Lan
collection PubMed
description Platelet-derived growth factor-BB (PDGF-BB) and its downstream effector, extracellular signal-regulated kinase 1/2 (ERK1/2) MAP kinase, initiate a multitude of biological effects, including vascular smooth muscle cell (VSMC) proliferation and migration, which are critical events in the initiation and development of restenosis following percutaneous transluminal coronary angioplasty (PTCA). Styryl lactones are natural products that have been demonstrated to possess anti-proliferative activities. Goniolactone C is a styryl lactone derivative that was first extracted from Goniothalamus cheliensis Hu. In the present study, we investigated the effects of goniolactone C on VSMC migration and proliferation. We found that goniolactone C preferentially interacted with cellular systems that rely on PDGF signaling but not those that rely on epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) signaling. Goniolactone C strongly inhibited PDGF-BB-induced VSMC migration and proliferation. goniolactone C-mediated inhibition of VSMC proliferation was associated with cell cycle arrest, while goniolactone C-mediated inhibition of VSMC migration was associated with the suppression of adhesion molecule expression. In addition, goniolactone C directly inhibited PDGFR-β kinase activity, thereby blocking the downstream effector of PDGF-BB. Thus, the results of the present study suggest a novel adjunctive pharmacological strategy that may be used to prevent angioplasty-related restenosis.
format Online
Article
Text
id pubmed-6271974
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62719742018-12-28 Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling Sun, Lan Zhao, Rui Lan, Xi Chen, Ruoyun Wang, Si Du, Guanhua Molecules Article Platelet-derived growth factor-BB (PDGF-BB) and its downstream effector, extracellular signal-regulated kinase 1/2 (ERK1/2) MAP kinase, initiate a multitude of biological effects, including vascular smooth muscle cell (VSMC) proliferation and migration, which are critical events in the initiation and development of restenosis following percutaneous transluminal coronary angioplasty (PTCA). Styryl lactones are natural products that have been demonstrated to possess anti-proliferative activities. Goniolactone C is a styryl lactone derivative that was first extracted from Goniothalamus cheliensis Hu. In the present study, we investigated the effects of goniolactone C on VSMC migration and proliferation. We found that goniolactone C preferentially interacted with cellular systems that rely on PDGF signaling but not those that rely on epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) signaling. Goniolactone C strongly inhibited PDGF-BB-induced VSMC migration and proliferation. goniolactone C-mediated inhibition of VSMC proliferation was associated with cell cycle arrest, while goniolactone C-mediated inhibition of VSMC migration was associated with the suppression of adhesion molecule expression. In addition, goniolactone C directly inhibited PDGFR-β kinase activity, thereby blocking the downstream effector of PDGF-BB. Thus, the results of the present study suggest a novel adjunctive pharmacological strategy that may be used to prevent angioplasty-related restenosis. MDPI 2014-11-26 /pmc/articles/PMC6271974/ /pubmed/25432005 http://dx.doi.org/10.3390/molecules191219501 Text en © 2014 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sun, Lan
Zhao, Rui
Lan, Xi
Chen, Ruoyun
Wang, Si
Du, Guanhua
Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling
title Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling
title_full Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling
title_fullStr Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling
title_full_unstemmed Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling
title_short Goniolactone C, a Styryl Lactone Derivative, Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Migration and Proliferation via PDGFR/ERK Signaling
title_sort goniolactone c, a styryl lactone derivative, inhibits pdgf-bb-induced vascular smooth muscle cell migration and proliferation via pdgfr/erk signaling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271974/
https://www.ncbi.nlm.nih.gov/pubmed/25432005
http://dx.doi.org/10.3390/molecules191219501
work_keys_str_mv AT sunlan goniolactonecastyryllactonederivativeinhibitspdgfbbinducedvascularsmoothmusclecellmigrationandproliferationviapdgfrerksignaling
AT zhaorui goniolactonecastyryllactonederivativeinhibitspdgfbbinducedvascularsmoothmusclecellmigrationandproliferationviapdgfrerksignaling
AT lanxi goniolactonecastyryllactonederivativeinhibitspdgfbbinducedvascularsmoothmusclecellmigrationandproliferationviapdgfrerksignaling
AT chenruoyun goniolactonecastyryllactonederivativeinhibitspdgfbbinducedvascularsmoothmusclecellmigrationandproliferationviapdgfrerksignaling
AT wangsi goniolactonecastyryllactonederivativeinhibitspdgfbbinducedvascularsmoothmusclecellmigrationandproliferationviapdgfrerksignaling
AT duguanhua goniolactonecastyryllactonederivativeinhibitspdgfbbinducedvascularsmoothmusclecellmigrationandproliferationviapdgfrerksignaling